Dec 08, 2021 / 07:00PM GMT
Unidentified Participant
Welcome to SNN Network Canada Virtual Event. I'd like to introduce our next presenter, Mark Williams of Marvell Biosciences, listed under TSX Venture under the symbol MRVL.
Sir, the floor is yours.
Mark Williams - Marvel Biosciences Corp. - President, Chief Science Officer & Director
Thanks very much, and thank you to everyone participating this afternoon. This is our disclaimer, which you can read at your leisure and apologize for the slight delay.
So briefly speaking, Marvell is a biotechnology company focused on developing essentially known --derivatives of known drugs. We call this process drug redevelopment. And because of that, we believe as a company that we can significantly lower the cost, the time, and the risk associated with bringing a new chemical entity to the market, because we know the original toxicity, we know the target and, we know elements of the drug that allow us to do that very, very quickly.
Between us, we have, as management team, more than 50 years of experience. We have two compounds
Marvel Biosciences Corp at SNN Network Canada Virtual Event Transcript
Dec 09, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers